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Maltocin P28 is a phage-tail like bacteriocin produced by Stenotrophomonas maltophilia
P28. The ORF8 of maltocin P28 gene cluster is predicted to encode an endolysin and
we name it endolysin P28. Sequence analysis revealed that it contains the lysozyme_like
superfamily conserved domain. Endolysin P28 has the four consensus motifs as that of
Escherichia coli phage lambda gpR. In this study, endolysin P28 was expressed in E. coli
BL21 (DE3) and purified with a C-terminal oligo-histidine tag. The antibacterial activity
of endolysin P28 increased as the temperature rose from 25 to 45◦C. Thermostability
assays showed that endolysin P28 was stable up to 50◦C, while its residual activity
was reduced by 55% after treatment at 70◦C for 30 min. Acidity and high salinity
could enhance its antibacterial activity. Endolysin P28 exhibited a broad antibacterial
activity against 14 out of 16 tested Gram-positive and Gram-negative bacteria besides
S. maltophilia. Moreover, it could effectively lyse intact Gram-negative bacteria in
the absence of ethylenediaminetetraacetic acid as an outer membrane permeabilizer.
Therefore, the characteristics of endolysin P28 make it a potential therapeutic agent
against multi-drug-resistant pathogens.
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INTRODUCTION
Stenotrophomonas maltophilia is a Gram-negative bacillus and increasingly being recognized as
an important nosocomial pathogen (Looney et al., 2009; Brooke, 2012). It can cause serious
infections such as bacteremia, pneumonia, endocarditis, meningitis, urinary tract infections,
skin and soft tissue infections in immunocompromised patients (Falagas et al., 2009; Sood
et al., 2013; Hotta et al., 2014; Trignano et al., 2014; Guzoglu et al., 2015). The available
therapeutic option for invasive S. maltophilia infection is limited, as this pathogen shows high
levels of resistance to commonly used antibiotics (Sánchez, 2015). S. maltophilia not only
exhibits intrinsic multidrug resistance but also can acquire antibiotic resistance during therapy
like other pathogenic strains (Tan et al., 2008). Therefore, the novel treatment strategies and
the eﬀective antimicrobial agents are needed urgently to date for treatment of S. maltophilia
infections.
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Endolysins are enzymes encoded by phages at the end of
their replication cycle to degrade the peptidoglycan of the
host cell wall for cell lysis and release of the mature progeny
phage particles (Loessner, 2005). Due to the absence of an
outer membrane in Gram-positive bacteria, endolysins can
easily access the peptidoglycan of cell wall and destroy these
organisms when applied externally (Fischetti, 2010; Gilmer
et al., 2013). When the endolysins work with Gram-negative
bacteria, the chelating agents, like ethylenediaminetetraacetic
acid (EDTA), are often used to increase the bacterial outer
membrane permeability (Briers et al., 2011; Walmagh et al.,
2013). Endolysins have been reported to be applied in medicine,
control and detection of food-borne pathogens (Fischetti, 2008;
Grandgirard et al., 2008; Coﬀey et al., 2010; Schmelcher et al.,
2012). Endolysins can also be expressed by transgenic plants to
prevent infection by phytopathogenic bacteria (Oey et al., 2009).
Expanding databases of predicted proteins from the increasing
number of sequenced and annotated bacterial genomes present
a growing number of potential endolysins (Schmitz et al., 2010;
Farris and Steinberg, 2014). As multidrug-resistant strains are
becoming more prevalent, endolysins may be employed as
novel alternatives to antibiotics (Bragg et al., 2014; Yang et al.,
2014).
In the previous work, we have identiﬁed the maltocin P28
from S. maltophilia P28. The gene cluster of maltocin P28 is
presumed to have 23 open reading frames (ORFs), and ORF8
is predicted to encode an endolysin (Liu et al., 2013). Here we
designate this putative endolysin as endolysin P28. Sequence
analysis revealed that the endolysin P28 contained the lysozyme-
like superfamily conserved domain and its amino acid sequence
had high identity with that of lambda phage gpR. In this study, we
cloned the ORF8 into pET-26b(+) to express this endolysin gene
in Escherichia coli. The recombinant endolysin P28 was puriﬁed
and characterized. And the antibacterial activity of endolysin P28
against various Gram-negative and Gram-positive bacteria was
also detected.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Stenotrophomonas maltophilia P28 and E. coli BL21(DE3)
were routinely cultivated in LB broth at 30◦C. One hundred
microgram per milliliter of ampicillin or 50 μg/mL kanamycin
was added when necessary. Strains used for antimicrobial
spectrum determination were all cultured in LB broth. The
growth temperature was listed in Table 1. Most tested strains
were taken from China Center for Type Culture Collection
(CCTCC), the others were purchased from the American Type
Culture Collection (ATCC) and Aeromonas hydrophila strain
XS91-4-1 was kindly provided by Professor Aihua Li at Institute
of Hydrobiology, Chinese Academy of Sciences.
Plasmid Construction and
Transformation
DNA manipulations were performed according to standard
protocols (Sambrook, 1989). Genomic DNA of S. maltophilia P28










Bacillus subtilis CCTCC AB93017 30 >99
Listeria monocytogenes CCTCC AB209106 30 90.4
Staphylococcus aureus CCTCC AB91053 37 >99
Gram-negative bacteria
Aeromonas hydrophila XS91-4-1 30 47.1
Aeromonas salmonicida CCTCC AB98041 22 19.2
Enterobacter aerogenes CCTCC AB91102 37 58.3






Proteus vulgaris CCTCC AB91103 30 61.2
Pseudomonas
aeruginosa
ATCC 15692 30 70.6
Pseudomonas
fluorescens
CCTCC AB92001 30 0
Pseudomonas putida ATCC12633 30 34.7
Salmonella typhimurium CCTCC AB204062 37 0
Shigella flexneri CCTCC AB200061 37 >99
Xanthomonas citri ssp.
malvacearum
CCTCC AB96030 30 >99
aCCTCC, China Centre for Type Culture Collection.
was extracted using the genomic DNA extraction kit (TIANGEN,
China) and used as the template to amplify the ORF8 of maltocin
P28 gene cluster. Plasmid DNA was obtained with TIANprep
Mini Plasmid kit (TIANGEN, China).
Cloning, Expression, and Purification of
Endolysin P28
The ORF8 (putative endolysin gene) was ampliﬁed from the
genomic DNA of S. maltophilia P28 by polymerase chain reaction
(PCR). The PCR primers were endo-F (5′-CATATGACCGCCGC
TGCAGCCAG-3′) and endo-R (5′-CTCGAGCTGCAGGGCTC
CGCC-3′). Ampliﬁcation was performed in PTC100 (BioRad,
USA) with the following condition: 95◦C for 5 min, 30
cycles of 94◦C for 30 s, 55◦C for 30 s, 72◦C for 30 s, and
the ﬁnal extension with 72◦C for 10 min. The PCR product
was puriﬁed with Cycle-pure-Kit (OMEGA) and cloned
into pDM19-T vector to conﬁrm the sequence. Then the
recombinant plasmid pDM19-T-ORF8 was digested with
restriction enzymes NdeI and XhoI. The obtained 492-bp
fragment was puriﬁed and inserted into pET-26b(+) by
NdeI and XhoI, designating the recombinant plasmid pET-
26b-ORF8. The E. coli BL21 (DE3) was transformed with
plasmid pET-26b-ORF8. Transformants were cultivated in
LB broth containing 50 μg/mL kanamycin at 37◦C. Protein
expression was induced by adding 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) at OD600 0.5–0.8, followed by
incubation for 6 h at 30◦C. Bacterial cells were harvested at
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4◦C, suspended in binding buﬀer (0.5 M sodium chloride,
50 mM Tris-HCl, pH 7.5), and disrupted by sonication
on ice. The lysates were centrifugated at 13,000 g for
10 min. After centrifugation, the supernatant was passed
through a Ni-NTA column (Novagen). Puriﬁcation of
endolysin P28 was performed according to the manufacturer’s
instructions. The identity and purity of the protein were
conﬁrmed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). The gel was stained by Coomassie
brilliant blue R-250 to visualize the bands. The puriﬁed
endolysin P28 was stored at –20◦C after the buﬀer was
changed to the storage buﬀer (20 mM Tris-HCl, pH 7.0) by
ultraﬁltration.
Determination of the Lytic Activity
The antibacterial activity of endolysin P28 was assessed by CFU
reduction analysis as described previously (Rodriguez et al.,
2011). Exponentially growing cells were centrifuged to discard
the supernatant, and then the cell pellet was washed twice,
resuspended in 20 mM Tris-HCl buﬀer (pH 7.0) and adjusted
the OD600 to 0.5 ± 0.05. Puriﬁed endolysin (100 μL) was
added to 300 μL cell suspension. The volume of reaction
system was 400 μL. Generally the concentration of the endolysin
added was adjusted to 2 mg/mL and the working concentration
was 0.5 mg/mL. When the appropriate working concentration
was tested, the concentration of the puriﬁed endolysin was
changed while the reaction volumes of puriﬁed endolysin
(100 μL) and cell suspension (300 μL) remained unchanged.
After incubation for 1 h at 30◦C, the mixture was serially
diluted by 10-fold. To determine the survival rate, 100 μL 10-
fold serial dilutions were plated on LB agar in triplicate, then
colony forming units (CFUs) were counted after incubation
at 30◦C for 24 h. The number of CFUs between 30 and 300
on the spread plate was eﬀectively counted. The control was
performed by adding 100 μL 20 mM Tris-HCl buﬀer (pH
7.0) instead of endolysin P28. The antibacterial activity was
expressed as the bacterial counts decrease. This value was
calculated as the dead percentage referred to an untreated
control. In this study, all the data were statistically analyzed
by using the Origin8.1 program. Diﬀerence was investigated
by the T-test at the 5% level. All experiments were repeated
at least three times. The error bars represent the standard
deviations.
In order to analyze the eﬀect of EDTA, the above washed
S. maltophilia culture (OD600 0.5± 0.05) was incubated in 20mM
Tris-HCl buﬀer (pH 7.0) containing 0, 1 mM and 5 mM EDTA
for 30 min. After centrifugation to remove the EDTA, the cell
pellet was resuspended in 20 mM Tris-HCl buﬀer (pH 7.0). Then
the puriﬁed endolysin was added and its antibacterial activity was
determined as described above.
To evaluate the eﬀect of pH on endolysin lytic activity,
the endolysin (100 μL, 2.0 mg/mL) was added to 300 μL
S. maltophilia cells suspended with a variety of buﬀers: 20 mM
NaAc for pH 4.0 and pH 5.0, 20 mM Na2HPO4 -NaH2PO4
for pH 6.0, 20 mM Tris-HCl for pH 7.0, pH 8.0 and pH 9.0,
Glycine-NaOH for pH 10.0–12.0. The control was carried out
by adding 100 μL respective buﬀer instead of endolysin P28.
After incubation for 1 h at 30◦C, the CFUs of the mixture were
determined by 10-fold dilution and the antibacterial activity was
calculated as described above.
The inﬂuence of saline concentration on the lytic activity of
endolysin was tested with NaCl concentration from 50 to 400mM
to cell suspension. One hundred microliter puriﬁed endolysin
(2.5 mg/mL) was added to 300 μL exponentially growing cell
(OD600 0.5 ± 0.05), which was washed and resuspended in
20 mMTris-HCl buﬀer (pH 7.0). And then 100μL NaCl solution
of diﬀerent concentration was added to the mixture. The control
was performed by adding 100 μL 20 mM Tris-HCl buﬀer (pH
7.0) instead of endolysin P28. After incubation for 1 h at 30◦C, the
CFUs were determined by 10-fold dilution and the antibacterial
activity was calculated as described above.
In order to examine the eﬀect of diﬀerent temperatures on the
enzymatic activity of endolysin P28, 100 μL puriﬁed endolysin
(2.0 mg/mL) was added to 300 μL exponentially growing cell
(OD600 0.5 ± 0.05), which was washed and resuspended in
20 mM Tris-HCl buﬀer (pH 7.0). The control was performed
by adding 100 μL 20 mM Tris-HCl buﬀer (pH 7.0) instead of
endolysin P28. After incubation for 1 h at diﬀerent temperatures
(25–45◦C), the CFUswere determined by 10-fold dilution and the
antibacterial activity was calculated as described above.
Thermostability was tested by incubating endolysin P28
(2.0 mg/mL) in 30, 40, 50, 60, 70 for 30 min, and then
100 μL treated endolysin P28 was mixed with the above
washed S. maltophilia cells (OD600 0.5 ± 0.05). The control was
performed by adding 100 μL 20 mM Tris-HCl buﬀer (pH 7.0)
instead of endolysin P28. After incubation for 1 h at 30◦C, the
CFUs of the mixture were determined by 10-fold dilution and the
antibacterial activity was calculated as described above.
RESULTS
Sequence Analysis
Maltocin P28 is a novel phage tail-like bacteriocin produced
by S. maltophilia P28 and has been characterized previously
(Liu et al., 2013). The ORF8 of maltocin P28 gene cluster
was predicted to encode an endolysin designated as endolysin
P28. The deduced amino acid of endolysin P28 showed 48.48%
identity with that of phage lambda gpR, which is the lambda
lysozyme and function as a lytic transglycosylase. NCBI Blastp
revealed that endolysin P28 included a conserved domain
known as bacteriophage_lambda_lysozyme family. This family
of lysozymes contains four consensus motifs (Blackburn and
Clarke, 2001). Endolysin P28 has the same motifs, with the
essential catalytic residue (Glu25) in motif I as lambda lysozyme
gpR (Jespers et al., 1992) (Figure 1A). Compared with lambda
gpR, endolysin P28 contained an N-terminal hydrophobic region
(Figure 1B).
Expression and Purification of Endolysin
P28
Endolysin P28 was overproduced as a C-terminal 6× His-
tagged fusion protein which allowed puriﬁcation by immobilized
metal chelate aﬃnity chromatography. The elution fractions
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FIGURE 1 | Sequence analysis of endolysin P28. (A) Comparison of amino acid sequences between endolysin P28 and lambda gpR, the boxes indicate the four
consensus motifs. (B) Hydrophobicity analysis of endolysin P28.
were pooled and analyzed by 15% SDS-PAGE. A major protein
band was observed which correlated well with the calculated
mass of the endolysin P28 fusion protein (18.1 kDa; Figure 2).
The concentration of puriﬁed endolysin P28 was determined
according to the Bradford assay.
Lytic Activity of Endolysin P28
For antibacterial activity measurement, S. maltophilia P28 was
used as substrate for the puriﬁed endolysin. The lytic activity
of endolysin P28 was conducted by CFU reduction assay. The
addition of 125 μg/mL endolysin did not change the viable
numbers of S. maltophilia. When the endolysin concentration
rose more than 125 μg/mL, its antibacterial activity enhanced
as the concentration increased (Figure 3). When the endolysin
concentration was 500 μg/mL, the CFU number reduced about
a half. Thus the endolysin concentration of 500 μg/mL was
used as the standard to perform the following antibacterial
assays.
Gram-negative bacteria are more sensitive to endolysins
after they are treated with EDTA to enhance the permeability
of their outer membrane (Briers et al., 2011). To determine
the eﬀect of EDTA on the antimicrobial activity of endolysin
P28, both S. maltophilia P28 and Pseudomonas aeruginosa
ATCC15692 were treated with the diﬀerent concentrations
of EDTA for 30 min. The addition of EDTA led the cell
lysis of P. aeruginosa ATCC15692 to signiﬁcantly increase
compared with buﬀer alone. The viable cell number of P.
aeruginosa ATCC15692 was reduced more than 2 logs by
addition of 1 mM EDTA, while the sensitivity of S. maltophilia
P28 to endolysin was not aﬀected by addition of EDTA
(Figure 4). Thus, we did not add EDTA in the following
experiments.
Influence of Temperature, Salinity, and
pH on Endolysin P28 Antibacterial
Activity
Standard CFU reduction analysis was performed to analyze
the eﬀects of temperature, salinity, and pH on endolysin P28
antibacterial activity. The results showed that the antibacterial
activity increased with the increase of temperature from 25
to 45◦C (Figure 5A). And as the salt concentration increased
from 100 mM to 200 mM, the antibacterial activity increased
sharply. While the salt concentration up to 400 mM did
not enhance the antibacterial activity further (Figure 5C). As
for the eﬀect of pH on endolysin P28, the result revealed
that it had a relatively high lytic activity at a broad pH
range of 5.0–8.0 and was ineﬀective when pH rose to 11.0
(Figure 5B). The thermal stability of endolysin P28 was
characterized by challenges over a range of temperatures (30,
40, 50, 60, and 70◦C). Residual activity of endolysin P28
was reduced 55% by following treatment at 70◦C for 30 min
(Figure 5D).
Antibacterial Spectrum
To test the antibacterial spectrum of endolysin P28, we used
four Gram-positive and twelve Gram-negative bacteria as
substrates. Maltocin P28 only lyses S. maltophilia (Liu et al.,
Frontiers in Microbiology | www.frontiersin.org 4 November 2015 | Volume 6 | Article 1299
Dong et al. Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28
FIGURE 2 | Overproduction of endolysin P28 in Escherichia coli BL21
(DE3) cells. Shown is SDS-PAGE (15%) of the cellular proteins from 80 μL
cultures of bacteria. The gel was stained by Coomassie brilliant blue R-250 to
visualize the bands. E. coli BL21 (DE3; pET-26b-ORF8) before induction (lane
1) and 6 h after induction (1 mM IPTG; lane 2). The overexpressed
oligohistidine-tagged endolysin P28 was purified (lane 3). M, molecular
masses of reference proteins (Thermo Scientific; in kilodaltons).
FIGURE 3 | Lytic activity of different concentration endolysin P28
against Stenotrophomonasmaltophilia P28. One hundred microliter
purified endolysin P28 was mixed with 300 μL cell suspension (OD600
0.5 ± 0.05). The concentration of the purified endolysin was changed while
the reaction volumes of purified endolysin (100 μL) and cell suspension
(300 μL) remained unchanged. After incubation for 1 h at 30◦C, the CFUs of
the mixture was determined and the antibacterial activity was calculated as
described in the section “Materials and Methods”. The data were statistically
analyzed by using the Origin8.1 program. All experiments were repeated at
least three times. Mean values (±SD) are shown.
2013). Apparently endolysin P28 showed a broader antibacterial
spectrum than maltocin P28 (Table 1). Endolysin P28 was able
to lyse all of the tested Gram-positive bacteria and exhibited
high lytic activity against three Gram-negative bacteria, Klebsiella
FIGURE 4 | Lytic activity of endolysin P28 over a range of
ethylenediaminetetraacetic acid (EDTA). The viable cell numbers (CFUs)
of S. maltophilia P28 (A) and P. aeruginosa ATCC 15692 (B) after the addition
of 500 μg endolysin P28 were examined. The cells were treated with different
concentrations of EDTA (0, 1, 5 mM) for 30 min before the endolysin P28 was
added. After incubation for 1 h at 30◦C, the CFUs of the mixture was
determined and the antibacterial activity was calculated as described in the
section “Materials and Methods”. Error bars are the means ± standard
deviation of three independent assays.
pneumoniae ssp. pneumoniae, Shigella flexneri,Xanthomonas citri
ssp. malvacearum (Figure 6). However, no activity was detected
against P. fluorescens and Salmonella typhimurium.
DISCUSSION
The last decade has witnessed an increasing emergence of
drug-resistant pathogens. Thus it is important to develop new
alternatives to antibiotics. Phage endolysins have been reported
to have good potential as a therapeutic agent for bacterial
infections (Schmelcher et al., 2012). When added externally,
they can cause a hole in the cell wall of the target bacterium
through peptidoglycan digestion exerting a lethal eﬀect (Fischetti,
2010). In general, exogenous endolysin is highly active against
many Gram-positive species but ineﬀective against Gram-
negative bacteria. It is probably due to the outer membrane
existing in Gram-negative bacteria, which is impermeable to
macromolecules and makes a physical barrier for endolysin to
access the peptidoglycan layer (During et al., 1999; Fischetti,
2010).
Most endolysins from Gram-negative bacteriophage reported
have only a catalytic domain. Some of them have a modular
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FIGURE 5 | Conditions for the enzymatic activity of the endolysin P28. The antimicrobial activity was performed at different temperatures for 1 h in 20 mM
Tris-HCl buffer, pH 7.0 (A), and in buffers with different pH values for 1 h at 30◦C (B). The influence of saline concentration on the lytic activity of endolysin was tested
with different NaCl concentration to cell suspension for 1 h in 20 mM Tris-HCl buffer, pH 7.0 at 30◦C (C). Thermostability of endolysin P28 was conducted by
incubating endolysin P28 in different temperatures for 30 min, and then the residual activity was calculated as described in the CFU reduction assay (D). Error bars
are the means ± standard deviation of three independent assays.
structure composed of a C-terminal catalytic domain and
N-terminal cell wall binding domain (Briers et al., 2007; Fokine
et al., 2008; Fischetti, 2010; Callewaert et al., 2011;Walmagh et al.,
2013). Sequence analysis of endolysin P28 found no N-terminal
cell wall binding domain or speciﬁc catalytic domain, rather it
contained an N-terminal hydrophobic region (Figure 1B), which
formed a putative helix domain. Some endolysins from phages
of Gram-negative bacteria can destroy bacterial cells by means of
a mechanism completely independent of their enzymatic activity
(During et al., 1999; Orito et al., 2004). In these cases, it was found
that helix-forming amphipathic peptides containing basic amino
acid residues seem to interact with negatively charged membrane
elements, such as lipopolysaccharide in Gram-negative bacteria
(During et al., 1999; Lim et al., 2014). Therefore, we proposed that
the N-terminal hydrophobic region of endolysin P28 should have
the same function. Endolysin P28 showed a hydrolysis activity
against peptidoglycan of E. coli and Bacillus subtilis through the
turbidity reduction assay (data not shown). In addition to the
four consensus motifs between endolysin P28 and lambda gpR,
the catalytic residue Glu19 in lambda gpR playing an crucial
role in the interaction of the enzyme with the GlcNAc of the
peptidoglycan backbone is conserved in endolysin P28 (Glu25).
So, further studies regarding the functions of N-terminal helix
domain and Glu25 of endolysin P28 should be performed in the
future.
Endolysin P28 had a good thermal stability, and showed a
broad lytic spectrum against 14 out of 16 tested bacteria including
medically important genera Aeromonas, Bacillus, Escherichia,
Klebsiella, Listeria, Pseudomonas, Proteus, Salmonella, Shigella,
Staphylococcus, and Xanthomonas. Since all the Gram-negative
strains tested in this study are Gammaproteobacteria, further
investigation into the eﬀect of endolysin P28 on other bacterial
species outside the two clusters of Gram-positive bacteria
and Gammaproteobacteria is being carried out. Endolysin P28
could not lyse S. typhimurium and P. fluorescens. Gram-
negative pathogens were protected by the presence of an
outer membrane, preventing the entry of endolysins into the
cell and reach the peptidoglycan (Nikaido, 2003). EDTA is a
well-known used outer membrane permeabilizer that acts as
a chelator by removing stabilizing cations from the outer
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FIGURE 6 | Lytic activity of endolysin P28 against various
Gram-positive and Gram-negative strains. Various exponentially growing
bacteria were washed twice and resuspended in 20 mM Tris-HCl buffer (pH
7.0). Three hundred microliter bacterial suspension (OD600 0.5 ± 0.05) was
mixed with 100 μL purified endolysin P28. After incubation for 1 h at 30◦C,
the CFUs of the mixture was determined and the antibacterial activity was
calculated as described in the section “Materials and Methods”. Mean values
(±SD) are shown.
membrane (Oliveira et al., 2014). In this study, we also found
that EDTA could enhance the activity of endolysin P28 to
P. aeruginosa. However, the tested strains were not treated by
any outer membrane permeabilizer agent when the spectrum of
endolysin P28 was detected. Thus, the reason for endolysin P28
ineﬀective against some strains may be the endolysin P28 could
not pass through outer member and reach their peptidoglycans.
Several Salmonella phage endolysins, such as Lys68, SPN1S,
and SPN9CC, have been characterized (Lim et al., 2012, 2014;
Oliveira et al., 2014). They have a wide spectrum of antibacterial
activity against Gram-negative bacteria but no eﬀect on the
Gram-positive bacteria tested. More strains should be detected
to ascertain how the antibacterial spectrum of endolysin is
associated with the bacterial characteristics.
As S. maltophilia P28 is EDTA resistant, we have no wonder
that EDTA had no eﬀect on the sensitivity of S. maltophilia
P28 to endolysin P28. However, it is important to note that
endolysin P28 has antibacterial activity against other Gram-
negative bacteria without EDTA treatment. To our knowledge,
few endolysins and engineered phage lytic enzymes have been
reported to have this property (Lai et al., 2011; Lukacik et al.,
2012, 2013; Schmelcher et al., 2012). The antibacterial rate of
endolysin P28 was more than 99% against six tested strains,
which were three Gram-positive and three Gram-negative strains.
The viable cell numbers of three Gram-positive strains were
reduced about 2 logs, while the viable cell numbers of three
Gram-negative strains were reduced more than 3 logs, especially
the viable cell number of S. flexneri was reduced more than 5
logs (Figure 6). These results suggested that endolysin P28 is
a potential therapeutic agent against both Gram-positive and
Gram-negative pathogenic strains.
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